Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Phase II Trial Evaluating Stereotactic Body Radiotherapy (SBRT) on Ultra-central Lung Tumors on MR-Linac (Magnetic Resonance Image-Guided Radiotherapy)

NCT07733219 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT07733219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07733219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Phase II Trial Evaluating Stereotactic Body Radiotherapy (SBRT) on Ultra-central Lung Tumors on MR-Linac (Magnetic Resonance Image-Guided Radiotherapy)
Lead sponsor
Centre Oscar Lambret
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
November 1, 2031
Enrollment
59 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (t1 n0 m0 and t2 n0 m0), mediastinal lymph node recurrence from all types of primary cancer, pulmonary node recurrence from all types of primary cancer, ultracentral pulmonary tumors